Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, et al. N Engl J Med 2024 Jun 8. doi: 10.1056/NEJMoa2401943.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, et al. Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. N Engl J Med 2024 Jun 8. doi: 10.1056/NEJMoa2401943.
PMID: 38856224